This brand name is authorized in Hong Kong
The drug BAMBI contains one active pharmaceutical ingredient (API):
|
1
Bambuterol
UNII 786Q84QZ3F - BAMBUTEROL HYDROCHLORIDE
|
|
Bambuterol is an active precursor of the selective β2-adrenergic agonist terbutaline. Bambuterol is the bis-N,N-dimethyl-carbamate of terbutaline. Bambuterol is a remarkably selective and potent inhibitor of cholinesterase. Bambuterol is indicated for the management of asthma, bronchospasm and/or reversible airways obstruction. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03CC12 | Bambuterol | R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HK | Department of Health Drug Office | Identifier(s): 67027 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
